Please provide your email address to receive an email when new articles are posted on . Takeda recently announced it is issuing a U.S. recall for all doses of its parathyroid hormone injection due to ...

Takeda took a big hit to its reputation after a U.S. recall of rare disease med Natpara last year. The reason? Rubber particles that could shed into drug vials. Now, the FDA is putting Takeda on ...

Particle contamination has proved a stumbling block for many drug manufacturers in recent years. Now, Japan's Toyobo is learning that lesson the hard way. The FDA has taken out its red pen to chide ...

The pharmaceutical and biopharmaceutical industries continue to embrace the utilization of single-use systems (SUS). With the ever-growing adoption of SUS products, increasing scrutiny has been placed ...